tradmap

XYL Financials Xylem

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 14.8% per year over the past 5 years.
  • Net income has grown faster than revenue (30.4% vs 14.8% per year).
  • Free cash flow has grown 7.3% per year over the past 5 years.

Financial health

  • Total debt ($1.9B) exceeds cash ($1.5B); net debt is $463M.
  • Total debt has grown slower than revenue (-8.8% vs 14.8% per year).
  • Operating income covered interest expense 42× in the latest year.
  • Total debt is 1.1× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 40.9% of earnings and 43.0% of free cash flow.
  • The dividend has grown 15.8% per year over the past 5 years.
Revenue & net income
$0 $5B $9B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 19% 38% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 10% 20% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $471M $942M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $2B $3B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$2B -$312M $1B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $9.0B $957M 38.5% 13.5% 8.3% 5.4% $910M $1.9B $1.5B
2024 $8.6B $890M 37.5% 11.8% 8.4% 5.4% $942M $2.0B $1.1B
2023 $7.4B $609M 36.9% 8.9% 6.0% 3.8% $566M $2.3B $1.0B
2022 $5.5B $355M 37.7% 11.3% 10.2% 4.5% $388M $1.9B $944M
2021 $5.2B $427M 38.0% 11.3% 13.3% 5.2% $330M $2.4B $1.3B
2020 $254M 8.6% 2.9% $641M $3.1B $1.9B
2019 $401M 13.6% 5.2% $613M $2.3B $724M
2018 $549M 19.8% 7.6% $349M $2.3B $296M
2017 $331M 13.2% 4.8% $516M $2.2B $414M
2016 $260M 11.9% 4.0% $373M $2.4B $308M
2015 $340M 16.3% 7.3% $347M $1.3B $680M
2014 $337M 15.8% 7.0% $297M $1.3B $663M
2013 $228M 10.2% 4.7% $198M $1.2B $533M
2012 $297M 14.3% 6.3% $284M $1.2B $504M
2011 $279M 15.2% 6.3% $323M $1.2B $318M

Valuation over time

How the market has priced XYL against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 37.6 75.2 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 2.4 4.8 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 0.8 1.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is XYL growing its revenue and profit?

Over the past 5 years, Xylem's revenue has grown 14.8% per year, and net income grown 30.4% per year. These are computed facts, not advice.

How much debt does XYL have?

As of FY2025, Xylem reported $1.9B of total debt against $1.5B of cash; operating income covered interest expense 42×.

What is XYL's profit margin?

In FY2025, gross margin was 38.5%, operating margin 13.5%, and net margin 10.6%.

What is XYL's P/E ratio?

As of Sep '26, Xylem traded at a price-to-earnings ratio of about 26.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.